Back to profiles

Andrea Bailey PhD

Montreal, Canada Area

As an independent scientific consultant, I have developed a pragmatic, solutions-oriented approach to problem solving. I provide cost-effective, strategic solutions tailored for the Life Sciences research Industry, influencing both management and business decisions. Committed to serving the needs of my clients, I am ever expanding my knowledge base; gaining insight across a number of disciplines including pharmacoeconomics, epidemiology, drug development, health policy, regulatory affairs and the pharmaceutical marketplace

Expert
$1/min
(0)
Request a Call

On-demand, expert advice.

Areas of Expertise

  • Scientific Research and Experimental Development Tax Credits

    Objective: To provide professional quality guidance in the preparation of Scientific Research & Experimental Development (SR&ED) claims to the Canadian Revenue Agency Contributions: Strategic scientific consulting Enhanced the success of SR&ED claims • Performed a systematic scientific review of SR&ED project information documentation (CRA Form T661, Part 2) o Ensured all project descriptions f

    • Research and Clinical
    • Other
    • Medical Writing
    • Clinical Research
    • Scientific Writing
    • SRED
  • Strategic Scientific Consultant

    Objective: Support the development and commercialization of novel, leading-edge therapeutics. Contributions: Functioned as a liaison between scientists, physicians and biotechnologists and investors. Influenced business decisions: • Advised the board of directors regarding the scientific merit of novel therapeutics with potential commercial interest • Apprised

    • Research and Clinical
    • Preclinical
    • Medical Writing
    • Research Strategy
    • Pharmacoeconomics
    • Preclinical Development
    • commercialization
  • Strategic Scientific Consultant

    Objective: To provide highly specific, cost-effective solutions for a newly developed research methodology. Contributions: Strategic management consulting: • Comparative analysis of research methodologies and their adaptability to new technological approaches • Created a specifically designed data sheet containing relevant information for making informed decisions at a glance Strategic scientifi

    • Research and Clinical
    • Preclinical
    • Pain
    • Research Methodologies
    • Research Strategy
    • Scientific Writing

My Interests

Health Sectors
Medical Devices, Biotech, Pharmaceuticals
Markets, Health Indications, Health Issues
  • Pharmaceuticals
  • commercialization
  • Research
Geographies
  • Montreal, Canada
  • Canada

Experience

  • Independent Scientific Consultant

    Independent Scientific Consultant SR & ED R&D Capital | August 2014 - September 2014

    Objective: To provide professional quality guidance in the preparation of Scientific Research & Experimental Development (SR&ED) claims to the Canadian Revenue Agency Contributions: Strategic scientific consulting Enhanced the success of SR&ED claims • Performed a systematic scientific review of SR&ED project information documentation (CRA Form T661, Part 2) o Ensured all project descriptions fell within the definition of Scientific Research and Experimental Development contained within the Income Tax Act. • Provided strategic scientific solutions for enhancing the claimant’s opportunity to receive their full entitlement allowed under the Income Tax Act.

  • Strategic Scientific Consultant

    Accelerated Ventures | November 2013 - July 2014

    Objective: Support the development and commercialization of novel, leading-edge therapeutics. Contributions: Functioned as a liaison between scientists, physicians and biotechnologists and the Accelerated Ventures board of directors Influenced business decisions: • Advised the board of directors regarding the scientific merit of novel therapeutics with potential commercial interest • Apprised the board of directors of the critical factors associated with the commercialization of new therapeutics o Pharmacoeconomics: the value of currently available therapies in comparison with the projected costs associated with the novel therapies in development o Epidemiology: incidence and prevalence of a number of diseases/conditions across therapeutic areas (oncology, neurodegenerative diseases, diabetes, immunology) • Kept apprised of collaborative partnerships between the government, the pharmaceutical industry and the research community.

  • Strategic Scientific Consultant

    Quebec Pain Research Network- Centre de Recherche Institut universitaire en santé mentale de Québec | April 2013 - June 2013

    Objective: To provide highly specific, cost-effective solutions for a newly developed research methodology. Contributions: Strategic management consulting: • Comparative analysis of research methodologies and their adaptability to new technological approaches • Created a specifically designed data sheet containing relevant information for making informed decisions at a glance Strategic scientific consulting • Proposed alternative approaches to circumvent inherent limitations associated with available technologies

Education

  • McGill University

    Doctorate | Pharmacology and Therapeutics | 2001 - 2009

  • McGill University

    Bachelors of Science | Anatomy and Cell Biology | 1998 - 2001

  • Dawson College

    D.E.C | Health Science | 1995 - 1998